Conversely, this was reverted when BCL-xL was downregulated via shRNA, and the latter cells were extremely sensitive to actinomycin D, which is highly reminiscent of results obtained with MCL-1 knockdown in GBM cells exposed to BH3 mimetics [19]. This evidence concerns the gene BCL2L1 and glioblastoma.